Research trends of cellular immunotherapy for primary liver cancer: A bibliometric analysis DOI Creative Commons

Xiang’an Wu,

Yuxin Wang, Xiao Liu

и другие.

Human Vaccines & Immunotherapeutics, Год журнала: 2024, Номер 20(1)

Опубликована: Ноя. 13, 2024

Cellular immunotherapy has shown considerable potential for the treatment of primary liver cancer (PLC), particularly hepatocellular carcinoma (HCC), although it is in early stages development. This study used bibliometric methods to delineate evolution research on cellular PLC. Data were sourced from Web Science Core Collection (WoSCC) April 22, 2024. Using "Bibliometrix" R package, we examined features, collaboration frequency between countries, and article output journals. Furthermore, employed VOSviewer coauthorship analysis visualization CiteSpace assess keyword co-occurrence, as well spotlight keywords references with strongest citation bursts. Our encompassed 492 publications focused PLC immunotherapy, pinpointed China, Japan, USA foremost contributing nations identified "Cancer Immunology Immunotherapy" journal most contributions this area. Sun Yat-sen University emerged institution significant output, Li Zonghai authored greatest number leading articles. Prominent that displayed a notable burst later years included "chimeric antigen receptor," "combination therapy", "CAR-T cells," "TCR-T "liver transplantation." outlined foundational knowledge framework, surveyed over three decades PLC, revealed key players trends, thereby offering thorough understanding field, especially relation HCC.

Язык: Английский

Research trends of cellular immunotherapy for primary liver cancer: A bibliometric analysis DOI Creative Commons

Xiang’an Wu,

Yuxin Wang, Xiao Liu

и другие.

Human Vaccines & Immunotherapeutics, Год журнала: 2024, Номер 20(1)

Опубликована: Ноя. 13, 2024

Cellular immunotherapy has shown considerable potential for the treatment of primary liver cancer (PLC), particularly hepatocellular carcinoma (HCC), although it is in early stages development. This study used bibliometric methods to delineate evolution research on cellular PLC. Data were sourced from Web Science Core Collection (WoSCC) April 22, 2024. Using "Bibliometrix" R package, we examined features, collaboration frequency between countries, and article output journals. Furthermore, employed VOSviewer coauthorship analysis visualization CiteSpace assess keyword co-occurrence, as well spotlight keywords references with strongest citation bursts. Our encompassed 492 publications focused PLC immunotherapy, pinpointed China, Japan, USA foremost contributing nations identified "Cancer Immunology Immunotherapy" journal most contributions this area. Sun Yat-sen University emerged institution significant output, Li Zonghai authored greatest number leading articles. Prominent that displayed a notable burst later years included "chimeric antigen receptor," "combination therapy", "CAR-T cells," "TCR-T "liver transplantation." outlined foundational knowledge framework, surveyed over three decades PLC, revealed key players trends, thereby offering thorough understanding field, especially relation HCC.

Язык: Английский

Процитировано

1